U.S. federal trademark · Serial No. 79034631 · Reg. No. 3395110
Anticancer drugs; antitumor drugs; antineoplastic drugs; drugs for medical purposes, namely, Retinoic acid Receptor agonist for the treatment of autoimmune/inflammatory diseases, vascular diseases, neurodegenerative diseases, psoriasis, palmoplantar pustulosis, wrinkles, and severe acne
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.